Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Oesophagogastric Cancer × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 80 Colorectal Neoplasms 42 Rectal Neoplasms 41 Carcinoma, Non-Small-Cell Lung 28 Esophageal Neoplasms 22 Lung Neoplasms 20 Esophageal Squamous Cell Carcinoma 20 Stomach Neoplasms 17 Pancreatic Neoplasms 17 Neoplasms 14 Colonic Neoplasms 13 Carcinoma, Hepatocellular 13 Neoplasm Metastasis 12 Squamous Cell Carcinoma of Head and Neck 11 Ovarian Neoplasms 11 Adenocarcinoma Of Esophagus 11 Urinary Bladder Neoplasms 10 Sarcoma 10 Prostatic Neoplasms 10 Head and Neck Neoplasms 10 Uterine Cervical Neoplasms 8 Fallopian Tube Neoplasms 8 Osteosarcoma 7 Inflammatory Breast Neoplasms 7 Central Nervous System Neoplasms 7 Multiple Myeloma 6 Liver Neoplasms 6 Carcinoma, Intraductal, Noninfiltrating 6 Recurrence 5 Kidney Neoplasms 5

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡